Good points in both post -- bill. I don't believe Amgen will get...

First 43 Last

Share
Profile

Follow
Naish

2,061 Posts.

11/02/16

17:30

Post #: 16997967
Share

Originally posted by billwilliams ↑

Fair point. I worded it poorly.

I don't think Amgen wants either, but a strategic stake is far easier than a buy out. What they would really like is for UNS to get their proverbial together, so they could be confident of supply going forward without having to do anything. I am guessing, however, that they don't see that happening without significant intervention.

A shareholding doesn't entitle you to a board seat (unless you take the company over), but you are likely to be able to vote directors in. In most cases, if a major shareholder asks for a seat, they will be given one. An angry holder with even 10% of a company's stock can cause a company a tremendous amount of grief. Easier just to make them feel included.

My line was really about what Amgen would want, not a lower limit on what they would agree to. At a minimum, they would demand very, very tight control on expenditure, principally R&D.

Agreed, you would get growth from Amgen products.

It is always possible that another player may emerge, creating some competitive tension. If that were the case, though, UNS wouldn't have extended the agreement with Amgen or they would have charged them a motza to extend it.

Expand

Good points in both post -- bill.
I don't believe Amgen will get board seat/s. Usually need better than 20% - not always though.
Don't believe in the t/o theory either - not mentioned in the doc about the negotiations.
Company's need truth in announcements.
But somehow will want to have this ship run a lot better.
Trim the fat like Orbi for awhile.

JMO but I think Amgen may support UNS until viable and then sell out.

UNS Price at posting: 23.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

EXR

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

Essential Energy conference: Streamlining approvals key to the green energy transition

There are more pages in this discussion • 10 more messages in this thread...

First 43 Last

Add UNS (ASX) to my watchlist

Good points in both post -- bill. I don't believe Amgen will get...

Top Stories

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

Essential Energy conference: Streamlining approvals key to the green energy transition

Featured News